Compounds > ci 988
Page last updated: 2024-09-02

ci 988 and Panic Attacks

ci 988 has been researched along with Panic Attacks in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adams, JB; Costa, J; Cutler, NR; Greiner, M; Pande, AC; Pierce, MW; Pyke, RE; Schweizer, E; Wilcox, CS; Wisselink, PG1
Adams, JB; Cook, J; Cowley, DS; Pyke, RE; Roy-Byrne, PP; Wingerson, D; Zaccharias, P1
den Boer, JA; Pande, AC; Slaap, B; van Es-Radhakishun, F; van Megen, HJ; Westenberg, HG1
Adams, JB; Greiner, M; Lydiard, RB; Pande, AC; Pierce, MW1

Trials

4 trial(s) available for ci 988 and Panic Attacks

ArticleYear
A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Colonic Diseases, Functional; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Male; Meglumine; Panic Disorder; Personality Inventory; Phobic Disorders; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Somatoform Disorders; Treatment Outcome

1995
Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panic.
    Biological psychiatry, 1996, Sep-15, Volume: 40, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Heart Rate; Humans; Indoles; Lactic Acid; Male; Meglumine; Panic Disorder; Psychiatric Status Rating Scales; Receptors, Cholecystokinin

1996
The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients.
    Psychopharmacology, 1997, Volume: 129, Issue:3

    Topics: Adolescent; Adult; Anti-Anxiety Agents; Cross-Over Studies; Double-Blind Method; Female; Humans; Hydrocortisone; Indoles; Male; Meglumine; Middle Aged; Panic Disorder; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Tetragastrin; Treatment Outcome

1997
Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder.
    Biological psychiatry, 1999, Sep-15, Volume: 46, Issue:6

    Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Indoles; Meglumine; Middle Aged; Panic Disorder; Receptors, Cholecystokinin

1999